calcium channel, voltage-dependent, gamma subunit 4 |
ITRACONAZOLE |
Calcium Channel Type L, Benzothiazepine |
68% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 3 |
ITRACONAZOLE |
Calcium Channel Type L, Benzothiazepine |
68% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 2 |
ITRACONAZOLE |
Calcium Channel Type L, Benzothiazepine |
68% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 1 |
ITRACONAZOLE |
Calcium Channel Type L, Benzothiazepine |
68% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 4 subunit |
ITRACONAZOLE |
Calcium Channel Type L, Benzothiazepine |
68% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 3 subunit |
ITRACONAZOLE |
Calcium Channel Type L, Benzothiazepine |
68% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 2 subunit |
ITRACONAZOLE |
Calcium Channel Type L, Benzothiazepine |
68% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
ITRACONAZOLE |
Calcium Channel Type L, Benzothiazepine |
68% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha 1F subunit |
ITRACONAZOLE |
Calcium Channel Type L, Benzothiazepine |
68% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type II, beta |
SIBUTRAMINE |
Sodium Channel, Site 2 |
65% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type II, alpha 2 |
SIBUTRAMINE |
Sodium Channel, Site 2 |
65% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type I, beta |
SIBUTRAMINE |
Sodium Channel, Site 2 |
65% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type I, alpha |
SIBUTRAMINE |
Sodium Channel, Site 2 |
65% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type IV, beta |
SIBUTRAMINE |
Sodium Channel, Site 2 |
65% |
NoneNone |
NoneNone |
View
|
sodium channel associated protein 1 |
SIBUTRAMINE |
Sodium Channel, Site 2 |
65% |
NoneNone |
NoneNone |
View
|
sodium channel associated protein 2 |
SIBUTRAMINE |
Sodium Channel, Site 2 |
65% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type III, beta |
SIBUTRAMINE |
Sodium Channel, Site 2 |
65% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type I, alpha |
SIBUTRAMINE |
Sodium Channel, Site 2 |
65% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type IX, alpha |
SIBUTRAMINE |
Sodium Channel, Site 2 |
65% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type VII, alpha |
SIBUTRAMINE |
Sodium Channel, Site 2 |
65% |
NoneNone |
NoneNone |
View
|
amiloride-sensitive cation channel 5, intestinal |
SIBUTRAMINE |
Sodium Channel, Site 2 |
65% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type III, beta |
SIBUTRAMINE |
Sodium Channel, Site 2 |
65% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type VIII, alpha polypeptide |
SIBUTRAMINE |
Sodium Channel, Site 2 |
65% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type XI, alpha |
SIBUTRAMINE |
Sodium Channel, Site 2 |
65% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type I, beta |
SIBUTRAMINE |
Sodium Channel, Site 2 |
65% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type 10, alpha polypeptide |
SIBUTRAMINE |
Sodium Channel, Site 2 |
65% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type IV, alpha polypeptide |
SIBUTRAMINE |
Sodium Channel, Site 2 |
65% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type V, alpha polypeptide |
SIBUTRAMINE |
Sodium Channel, Site 2 |
65% |
NoneNone |
NoneNone |
View
|
dopamine receptor D3 |
BENZETHONIUM CHLORIDE |
Dopamine D3 |
65% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 1A |
PHENTOLAMINE |
Serotonin 5-HT1A |
65% |
NoneNone |
NoneNone |
View
|
phosphodiesterase 5A, cGMP-specific |
CANDESARTAN |
Phosphodiesterase PDE5 |
65% |
NoneNone |
NoneNone |
View
|
phosphodiesterase 5A, cGMP-specific |
CANDESARTAN |
Phosphodiesterase PDE5 |
65% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, muscarinic 1 |
RALOXIFENE |
Muscarinic M1 |
65% |
NoneNone |
NoneNone |
View
|
Cytochrom P450-2C19 monooxygenase |
RALOXIFENE |
CYP450-2C19 Inhibition |
65% |
NoneNone |
NoneNone |
View
|
melanocortin 3 receptor |
ASTEMIZOLE |
Melanocortin MC3 |
65% |
15.525uM |
13.549uM |
View
|
melanocortin 3 receptor |
ASTEMIZOLE |
Melanocortin MC3 |
65% |
15.525uM |
13.549uM |
View
|
adrenergic receptor, alpha 2a |
DOXAZOSIN |
Adrenergic alpha2A |
65% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
EMETINE |
Calcium Channel Type L, Phenylalkylamine |
65% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
EMETINE |
Calcium Channel Type L, Phenylalkylamine |
65% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
EMETINE |
Calcium Channel Type L, Phenylalkylamine |
65% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 5 |
EMETINE |
Calcium Channel Type L, Phenylalkylamine |
65% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 4 |
EMETINE |
Calcium Channel Type L, Phenylalkylamine |
65% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 3 |
EMETINE |
Calcium Channel Type L, Phenylalkylamine |
65% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 2 |
EMETINE |
Calcium Channel Type L, Phenylalkylamine |
65% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 1 |
EMETINE |
Calcium Channel Type L, Phenylalkylamine |
65% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 4 subunit |
EMETINE |
Calcium Channel Type L, Phenylalkylamine |
65% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 3 subunit |
EMETINE |
Calcium Channel Type L, Phenylalkylamine |
65% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 2 subunit |
EMETINE |
Calcium Channel Type L, Phenylalkylamine |
65% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
EMETINE |
Calcium Channel Type L, Phenylalkylamine |
65% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha 1F subunit |
EMETINE |
Calcium Channel Type L, Phenylalkylamine |
65% |
NoneNone |
NoneNone |
View
|
adenosine A2a receptor |
ALPHA-NAPHTHOFLAVONE |
Adenosine A2A |
65% |
NoneNone |
NoneNone |
View
|
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
PACLITAXEL |
Protein Tyrosine Kinase, HER2 Receptor |
65% |
11.108uM |
NoneNone |
View
|
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
PACLITAXEL |
Protein Tyrosine Kinase, HER2 Receptor |
65% |
11.108uM |
NoneNone |
View
|
adenosine A2a receptor |
CLOTRIMAZOLE |
Adenosine A2A |
65% |
12.711uM |
7.136uM |
View
|
Cytochrom P450-2D6 monooxygenase |
CHLORPROMAZINE |
CYP450-2D6 Inhibition |
65% |
NoneNone |
NoneNone |
View
|
Protein-tyrosine kinase, Fyn |
CATECHOL |
Protein Tyrosine Kinase, Fyn |
65% |
17.431uM |
NoneNone |
View
|
adrenergic receptor, alpha 2b |
CYCLIZINE |
Adrenergic alpha2B |
65% |
NoneNone |
NoneNone |
View
|
adenosine A2a receptor |
THEOPHYLLINE |
Adenosine A2A |
65% |
12.007uM |
6.741uM |
View
|
adenosine A1 receptor |
THEOPHYLLINE |
Adenosine A1 |
65% |
17.104uM |
9.977uM |
View
|
cholinergic receptor, muscarinic 4 |
FLUOXETINE |
Muscarinic M4 |
65% |
NoneNone |
NoneNone |
View
|
adrenergic receptor, alpha 2b |
FLAVOXATE |
Adrenergic alpha2C |
65% |
NoneNone |
NoneNone |
View
|
adrenergic receptor, alpha 2c (Non-specific probe) |
FLAVOXATE |
Adrenergic alpha2C |
65% |
NoneNone |
NoneNone |
View
|
Cytochrom P450-2D6 monooxygenase |
HALOPERIDOL |
CYP450-2D6 Inhibition |
65% |
NoneNone |
NoneNone |
View
|
Cytochrom P450-2C19 monooxygenase |
LETROZOLE |
CYP450-2C19 Inhibition |
65% |
NoneNone |
NoneNone |
View
|
phosphodiesterase 3B |
GENISTEIN |
Phosphodiesterase PDE3 |
65% |
11.013uM |
NoneNone |
View
|
phosphodiesterase 3A |
GENISTEIN |
Phosphodiesterase PDE3 |
65% |
11.013uM |
NoneNone |
View
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
TRIHEXYPHENIDYL |
Calcium Channel Type L, Benzothiazepine |
70% |
4.81uM |
4.275uM |
View
|
calcium channel, voltage-dependent, beta 2 subunit |
CLOTRIMAZOLE |
Calcium Channel Type L, Benzothiazepine |
70% |
28.499uM |
25.332uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
CLOTRIMAZOLE |
Calcium Channel Type L, Benzothiazepine |
70% |
28.499uM |
25.332uM |
View
|
calcium channel, voltage-dependent, alpha 1F subunit |
CLOTRIMAZOLE |
Calcium Channel Type L, Benzothiazepine |
70% |
28.499uM |
25.332uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1D subunit |
CLOTRIMAZOLE |
Calcium Channel Type L, Benzothiazepine |
70% |
28.499uM |
25.332uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
CLOTRIMAZOLE |
Calcium Channel Type L, Benzothiazepine |
70% |
28.499uM |
25.332uM |
View
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
CLOTRIMAZOLE |
Calcium Channel Type L, Benzothiazepine |
70% |
28.499uM |
25.332uM |
View
|
calcium channel, voltage-dependent, beta 1 subunit |
CLOTRIMAZOLE |
Calcium Channel Type L, Benzothiazepine |
70% |
28.499uM |
25.332uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1E subunit |
CLOTRIMAZOLE |
Calcium Channel Type L, Benzothiazepine |
70% |
28.499uM |
25.332uM |
View
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
CLOTRIMAZOLE |
Calcium Channel Type L, Benzothiazepine |
70% |
28.499uM |
25.332uM |
View
|
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
CLOTRIMAZOLE |
Calcium Channel Type L, Benzothiazepine |
70% |
28.499uM |
25.332uM |
View
|
acetylcholinesterase (YT blood group) |
CLOTRIMAZOLE |
Acetylcholinesterase |
70% |
19.41uM |
NoneNone |
View
|
collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase |
CLOTRIMAZOLE |
Acetylcholinesterase |
70% |
19.41uM |
NoneNone |
View
|
acetylcholinesterase |
CLOTRIMAZOLE |
Acetylcholinesterase |
70% |
19.41uM |
NoneNone |
View
|
adrenergic receptor, beta 3 |
AMIODARONE |
Adrenergic beta3 |
70% |
42.349uM |
31.761uM |
View
|
5-hydroxytryptamine (serotonin) receptor 2B |
TRETINOIN |
Serotonin 5-HT2B |
70% |
.358uM |
.228uM |
View
|
cytochrome P450, family 3, subfamily a, polypeptide 13 |
DIHYDROERGOTAMINE |
CYP450-3A4 Inhibition |
70% |
5uM |
NoneNone |
View
|
opioid receptor, kappa 1 |
BISACODYL |
Opiate kappa |
70% |
2.437uM |
.975uM |
View
|
adrenergic receptor, alpha 1a |
BRIMONIDINE |
Adrenergic alpha1A |
70% |
6.344uM |
2.568uM |
View
|
adrenergic receptor, alpha 1d (Non-specific probe) |
BRIMONIDINE |
Adrenergic alpha1D |
70% |
1.72uM |
.846uM |
View
|
cholinergic receptor, muscarinic 2 |
FLUPHENAZINE |
Muscarinic M2 |
70% |
7.481uM |
2.66uM |
View
|
melanocortin 5 receptor |
BENZOTHIAZYL DISULFIDE |
Melanocortin MC5 |
70% |
3.9uM |
3.7uM |
View
|
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 |
CAFFEIC ACID PHENETHYL ESTER |
Adrenergic, Norepinephrine Transporter |
70% |
3.787uM |
3.756uM |
View
|
arachidonate 15-lipoxygenase, second type |
TOLAZAMIDE |
Lipoxygenase 15-LO |
70% |
5.106uM |
NoneNone |
View
|
arachidonate 15-lipoxygenase |
TOLAZAMIDE |
Lipoxygenase 15-LO |
70% |
5.106uM |
NoneNone |
View
|
arachidonate 15-lipoxygenase |
TOLAZAMIDE |
Lipoxygenase 15-LO |
70% |
5.106uM |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 2B |
LABETALOL |
Serotonin 5-HT2B |
70% |
3.037uM |
1.933uM |
View
|
mu-opioid receptor MOR |
HALOPERIDOL |
Opiate mu |
70% |
2.443uM |
.992uM |
View
|
cathepsin G |
TRIAMTERENE |
Protease, Cathepsin G |
70% |
7.413uM |
NoneNone |
View
|
mast cell protease 9 |
TRIAMTERENE |
Protease, Cathepsin G |
70% |
7.413uM |
NoneNone |
View
|
A3 adenosine receptor |
CISPLATIN |
Adenosine A3 |
70% |
4.243uM |
2.398uM |
View
|
adrenergic receptor, alpha 1d (Non-specific probe) |
CITALOPRAM |
Adrenergic alpha1D |
70% |
3.289uM |
1.617uM |
View
|
5-hydroxytryptamine (serotonin) receptor 2B |
MEPAZINE |
Serotonin 5-HT2B |
70% |
.514uM |
.327uM |
View
|
Cytochrom P450-1A2 monooxygenase |
PHENYLHYDRAZINE |
CYP450-1A2 Inhibition |
70% |
8uM |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 2 |
L-744832 |
Calcium Channel Type L, Dihydropyridine |
70% |
4.501uM |
2.893uM |
View
|
calcium channel, voltage-dependent, gamma subunit 1 |
L-744832 |
Calcium Channel Type L, Dihydropyridine |
70% |
4.501uM |
2.893uM |
View
|
calcium channel, voltage-dependent, beta 4 subunit |
L-744832 |
Calcium Channel Type L, Dihydropyridine |
70% |
4.501uM |
2.893uM |
View
|
calcium channel, voltage-dependent, beta 3 subunit |
L-744832 |
Calcium Channel Type L, Dihydropyridine |
70% |
4.501uM |
2.893uM |
View
|
calcium channel, voltage-dependent, beta 2 subunit |
L-744832 |
Calcium Channel Type L, Dihydropyridine |
70% |
4.501uM |
2.893uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
L-744832 |
Calcium Channel Type L, Dihydropyridine |
70% |
4.501uM |
2.893uM |
View
|
calcium channel, voltage-dependent, alpha 1F subunit |
L-744832 |
Calcium Channel Type L, Dihydropyridine |
70% |
4.501uM |
2.893uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1D subunit |
L-744832 |
Calcium Channel Type L, Dihydropyridine |
70% |
4.501uM |
2.893uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
L-744832 |
Calcium Channel Type L, Dihydropyridine |
70% |
4.501uM |
2.893uM |
View
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
L-744832 |
Calcium Channel Type L, Dihydropyridine |
70% |
4.501uM |
2.893uM |
View
|
calcium channel, voltage-dependent, beta 1 subunit |
L-744832 |
Calcium Channel Type L, Dihydropyridine |
70% |
4.501uM |
2.893uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1E subunit |
L-744832 |
Calcium Channel Type L, Dihydropyridine |
70% |
4.501uM |
2.893uM |
View
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
L-744832 |
Calcium Channel Type L, Dihydropyridine |
70% |
4.501uM |
2.893uM |
View
|
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
L-744832 |
Calcium Channel Type L, Dihydropyridine |
70% |
4.501uM |
2.893uM |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
L-744832 |
Calcium Channel Type L, Dihydropyridine |
70% |
4.501uM |
2.893uM |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
L-744832 |
Calcium Channel Type L, Dihydropyridine |
70% |
4.501uM |
2.893uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1D subunit |
ITRACONAZOLE |
Calcium Channel Type L, Benzothiazepine |
68% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
ITRACONAZOLE |
Calcium Channel Type L, Benzothiazepine |
68% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
ITRACONAZOLE |
Calcium Channel Type L, Benzothiazepine |
68% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 1 subunit |
ITRACONAZOLE |
Calcium Channel Type L, Benzothiazepine |
68% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1E subunit |
ITRACONAZOLE |
Calcium Channel Type L, Benzothiazepine |
68% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
ITRACONAZOLE |
Calcium Channel Type L, Benzothiazepine |
68% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
ITRACONAZOLE |
Calcium Channel Type L, Benzothiazepine |
68% |
NoneNone |
NoneNone |
View
|
melanocortin 4 receptor |
RESERPINE |
Melanocortin MC4 |
68% |
NoneNone |
NoneNone |
View
|
dopamine receptor D3 |
OXYMETAZOLINE |
Dopamine D3 |
68% |
NoneNone |
NoneNone |
View
|
melanocortin 5 receptor |
EBASTINE |
Melanocortin MC5 |
68% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 1B |
DAPIPRAZOLE |
Serotonin 5-HT1B |
68% |
NoneNone |
NoneNone |
View
|
adrenergic receptor, alpha 2b |
DAPIPRAZOLE |
Adrenergic alpha2C |
68% |
NoneNone |
NoneNone |
View
|
adrenergic receptor, alpha 2c (Non-specific probe) |
DAPIPRAZOLE |
Adrenergic alpha2C |
68% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, muscarinic 4 |
RALOXIFENE |
Muscarinic M4 |
68% |
NoneNone |
NoneNone |
View
|
adrenergic receptor, alpha 2a |
DAPIPRAZOLE |
Adrenergic alpha2A |
68% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 2 |
TRIBROMSALAN |
Cyclooxygenase COX-2 |
68% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
TRIBROMSALAN |
Cyclooxygenase COX-2 |
68% |
NoneNone |
NoneNone |
View
|
adrenergic receptor, alpha 2b |
KETOCONAZOLE |
Adrenergic alpha2B |
68% |
18.047uM |
8.239uM |
View
|
thromboxane A synthase 1 |
METYRAPONE |
Thromboxane Synthetase |
68% |
NoneNone |
NoneNone |
View
|
thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) |
METYRAPONE |
Thromboxane Synthetase |
68% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, muscarinic 2 |
SULCONAZOLE |
Muscarinic M2 |
68% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
DANAZOL |
Calcium Channel Type L, Phenylalkylamine |
68% |
14.61uM |
14.198uM |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
DANAZOL |
Calcium Channel Type L, Phenylalkylamine |
68% |
14.61uM |
14.198uM |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
DANAZOL |
Calcium Channel Type L, Phenylalkylamine |
68% |
14.61uM |
14.198uM |
View
|
calcium channel, voltage-dependent, gamma subunit 5 |
DANAZOL |
Calcium Channel Type L, Phenylalkylamine |
68% |
14.61uM |
14.198uM |
View
|
calcium channel, voltage-dependent, gamma subunit 4 |
DANAZOL |
Calcium Channel Type L, Phenylalkylamine |
68% |
14.61uM |
14.198uM |
View
|
calcium channel, voltage-dependent, gamma subunit 3 |
DANAZOL |
Calcium Channel Type L, Phenylalkylamine |
68% |
14.61uM |
14.198uM |
View
|
calcium channel, voltage-dependent, gamma subunit 2 |
DANAZOL |
Calcium Channel Type L, Phenylalkylamine |
68% |
14.61uM |
14.198uM |
View
|
calcium channel, voltage-dependent, gamma subunit 1 |
DANAZOL |
Calcium Channel Type L, Phenylalkylamine |
68% |
14.61uM |
14.198uM |
View
|
calcium channel, voltage-dependent, beta 4 subunit |
DANAZOL |
Calcium Channel Type L, Phenylalkylamine |
68% |
14.61uM |
14.198uM |
View
|
calcium channel, voltage-dependent, beta 3 subunit |
DANAZOL |
Calcium Channel Type L, Phenylalkylamine |
68% |
14.61uM |
14.198uM |
View
|
calcium channel, voltage-dependent, beta 2 subunit |
DANAZOL |
Calcium Channel Type L, Phenylalkylamine |
68% |
14.61uM |
14.198uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
DANAZOL |
Calcium Channel Type L, Phenylalkylamine |
68% |
14.61uM |
14.198uM |
View
|
calcium channel, voltage-dependent, alpha 1F subunit |
DANAZOL |
Calcium Channel Type L, Phenylalkylamine |
68% |
14.61uM |
14.198uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1D subunit |
DANAZOL |
Calcium Channel Type L, Phenylalkylamine |
68% |
14.61uM |
14.198uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
DANAZOL |
Calcium Channel Type L, Phenylalkylamine |
68% |
14.61uM |
14.198uM |
View
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
DANAZOL |
Calcium Channel Type L, Phenylalkylamine |
68% |
14.61uM |
14.198uM |
View
|
calcium channel, voltage-dependent, beta 1 subunit |
DANAZOL |
Calcium Channel Type L, Phenylalkylamine |
68% |
14.61uM |
14.198uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1E subunit |
DANAZOL |
Calcium Channel Type L, Phenylalkylamine |
68% |
14.61uM |
14.198uM |
View
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
DANAZOL |
Calcium Channel Type L, Phenylalkylamine |
68% |
14.61uM |
14.198uM |
View
|
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
DANAZOL |
Calcium Channel Type L, Phenylalkylamine |
68% |
14.61uM |
14.198uM |
View
|
acetylcholinesterase (YT blood group) |
DIETHYLSTILBESTROL |
Acetylcholinesterase |
68% |
25.55uM |
NoneNone |
View
|
collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase |
DIETHYLSTILBESTROL |
Acetylcholinesterase |
68% |
25.55uM |
NoneNone |
View
|
acetylcholinesterase |
DIETHYLSTILBESTROL |
Acetylcholinesterase |
68% |
25.55uM |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 5B |
FLUTAMIDE |
Serotonin 5-HT4 |
68% |
13.545uM |
2.258uM |
View
|
5-hydroxytryptamine (serotonin) receptor 4 |
FLUTAMIDE |
Serotonin 5-HT4 |
68% |
13.545uM |
2.258uM |
View
|
androgen receptor |
BACITRACIN |
Testosterone |
68% |
NoneNone |
NoneNone |
View
|
androgen receptor |
RAPAMYCIN |
Testosterone |
68% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 2A |
TIRILAZAD |
Serotonin 5-HT2A |
68% |
2.002uM |
.572uM |
View
|
phosphodiesterase 4C, cAMP-specific |
CELECOXIB |
Phosphodiesterase PDE4 |
68% |
9.26uM |
NoneNone |
View
|
phosphodiesterase 4D |
CELECOXIB |
Phosphodiesterase PDE4 |
68% |
9.26uM |
NoneNone |
View
|
phosphodiesterase 4B, cAMP specific |
CELECOXIB |
Phosphodiesterase PDE4 |
68% |
9.26uM |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
DEXTROMETHORPHAN |
Calcium Channel Type L, Benzothiazepine |
66% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
DEXTROMETHORPHAN |
Calcium Channel Type L, Benzothiazepine |
66% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
DEXTROMETHORPHAN |
Calcium Channel Type L, Benzothiazepine |
66% |
NoneNone |
NoneNone |
View
|
sodium channel associated protein 1 |
PUROMYCIN |
Sodium Channel, Site 2 |
12% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 5 |
DEXTROMETHORPHAN |
Calcium Channel Type L, Benzothiazepine |
66% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 4 |
DEXTROMETHORPHAN |
Calcium Channel Type L, Benzothiazepine |
66% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 3 |
DEXTROMETHORPHAN |
Calcium Channel Type L, Benzothiazepine |
66% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 2 |
DEXTROMETHORPHAN |
Calcium Channel Type L, Benzothiazepine |
66% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 1 |
DEXTROMETHORPHAN |
Calcium Channel Type L, Benzothiazepine |
66% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, muscarinic 1 |
ALPHA-NAPHTHOFLAVONE |
Muscarinic M1 |
66% |
NoneNone |
NoneNone |
View
|
ATPase, Na+/K+ transporting, alpha 4 polypeptide |
TRANS-PLATINUM(II)DIAMMINE DICHLORIDE |
ATPase, Na+/K+ |
66% |
NoneNone |
NoneNone |
View
|
ATPase, Na+/K+ transporting, alpha 3 polypeptide |
TRANS-PLATINUM(II)DIAMMINE DICHLORIDE |
ATPase, Na+/K+ |
66% |
NoneNone |
NoneNone |
View
|
ATPase, Na+/K+ transporting, alpha 2 polypeptide |
TRANS-PLATINUM(II)DIAMMINE DICHLORIDE |
ATPase, Na+/K+ |
66% |
NoneNone |
NoneNone |
View
|
ATPase, Na+/K+ transporting, alpha 1 polypeptide |
TRANS-PLATINUM(II)DIAMMINE DICHLORIDE |
ATPase, Na+/K+ |
66% |
NoneNone |
NoneNone |
View
|
ATPase, Na+/K+ transporting, beta 1 polypeptide |
TRANS-PLATINUM(II)DIAMMINE DICHLORIDE |
ATPase, Na+/K+ |
66% |
NoneNone |
NoneNone |
View
|
ATPase, Na+/K+ transporting, beta 3 polypeptide |
TRANS-PLATINUM(II)DIAMMINE DICHLORIDE |
ATPase, Na+/K+ |
66% |
NoneNone |
NoneNone |
View
|
ATPase, Na+/K+ transporting, beta 2 polypeptide |
TRANS-PLATINUM(II)DIAMMINE DICHLORIDE |
ATPase, Na+/K+ |
66% |
NoneNone |
NoneNone |
View
|
ATPase, (Na+)/K+ transporting, beta 4 polypeptide |
TRANS-PLATINUM(II)DIAMMINE DICHLORIDE |
ATPase, Na+/K+ |
66% |
NoneNone |
NoneNone |
View
|
dopamine receptor D3 |
EPINEPHRINE |
Dopamine D3 |
66% |
NoneNone |
NoneNone |
View
|
dopamine receptor D1A |
CINNARIZINE |
Dopamine D1 |
66% |
NoneNone |
NoneNone |
View
|
cytochrome P450, family 3, subfamily a, polypeptide 13 |
CLEMASTINE |
CYP450-3A4 Inhibition |
66% |
NoneNone |
NoneNone |
View
|
Cytochrom P450-2D6 monooxygenase |
OXYBUTYNIN |
CYP450-2D6 Inhibition |
66% |
NoneNone |
NoneNone |
View
|
Cytochrom P450-2D6 monooxygenase |
SERTRALINE |
CYP450-2D6 Inhibition |
66% |
NoneNone |
NoneNone |
View
|
Cytochrom P450-2D6 monooxygenase |
AZTREONAM |
CYP450-2D6 Inhibition |
66% |
NoneNone |
NoneNone |
View
|
A3 adenosine receptor |
ALFACALCIDOL |
Adenosine A3 |
66% |
NoneNone |
NoneNone |
View
|
aldo-keto reductase family 1, member B4 (aldose reductase) |
ACEMETACIN |
Aldose Reductase |
66% |
NoneNone |
NoneNone |
View
|
aldo-keto reductase family 1, member B1 (aldose reductase) |
ACEMETACIN |
Aldose Reductase |
66% |
NoneNone |
NoneNone |
View
|
aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase) |
ACEMETACIN |
Aldose Reductase |
66% |
NoneNone |
NoneNone |
View
|
aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase) |
ACEMETACIN |
Aldose Reductase |
66% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
DIPHENIDOL |
Calcium Channel Type L, Benzothiazepine |
66% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
DIPHENIDOL |
Calcium Channel Type L, Benzothiazepine |
66% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
DIPHENIDOL |
Calcium Channel Type L, Benzothiazepine |
66% |
NoneNone |
NoneNone |
View
|